The latest price and market reference of Moboxetinib (Anvili) in 2025

Mobocertinib is an oral small molecule targeted drug, mainly used to treat patients with non-small cell lung cancer (NSCLC) with positive insertion mutations in exon 20 of EGFR. The drug is already on the market in China, but has not yet been included in medical insurance, which means that it is difficult for patients to directly purchase the original drug in China, and they have to bear all the costs themselves. For specific drug purchase situations, it is recommended that patients consult the local hospital pharmacy to learn about drug supply and price information.

In the domestic market, because moboxetinib has not yet been included in medical insurance, the price of the original drug is high and the channels are limited, making it difficult for patients to obtain it directly. When prescribing, doctors will provide advice based on the patient's condition and financial situation, and may guide patients to apply for drugs through formal channels or participate in clinical research projects to obtain drug supply. For patients in urgent need of treatment, reasonable planning of medication plans and financial arrangements is particularly important.

In overseas markets, mobosetinib has two options: original drug and generic drug. The original drugs mainly include the Hong Kong version and the Japanese Takeda version. The price is about 7,000 to 8,000 yuan, which is relatively high, but the quality and stability of the drug are guaranteed. This type of drug is a reliable choice for patients whose financial conditions permit and who wish to use original drugs. When purchasing, you should go through formal channels to ensure that the source of drugs is legal and meets transportation and storage standards.

In comparison, the prices of overseas generic drugs are more affordable. Among them, the price of the Laotian version of the generic drug Moboxetinib is about 3,000 yuan, which is about half of the original drug. Although the price is low, its pharmaceutical ingredients are basically the same as the original drugs and can achieve similar therapeutic effects. However, when purchasing overseas generic drugs, patients still need to pay attention to choosing legal and reliable channels, and use them under the guidance of professional doctors to ensure safety and efficacy. At the same time, combined with regular review and follow-up, scientific management of side effects can achieve the purpose of long-term stable treatment.

Reference link:https://www.drugs.com